We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.92B
AUM Growth
-$967M
Cap. Flow
-$852M
Cap. Flow %
-21.77%
Top 10 Hldgs %
42.44%
Holding
108
New
15
Increased
23
Reduced
16
Closed
19

Top Buys

Rank Stock Value
1
MANE
Veradermics Inc
MANE
+$210M
2
CAPR icon
Capricor Therapeutics
CAPR
+$54.2M
3
VMC icon
Vulcan Materials
VMC
+$53.4M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$46.6M
5
PFGC icon
Performance Food Group
PFGC
+$35.4M

Top Sells

Rank Stock Value
1
ERAS icon
Erasca
ERAS
+$131M
2
KO icon
Coca-Cola
KO
+$96.7M
3
MSFT icon
Microsoft
MSFT
+$64.7M
4
NOW icon
ServiceNow
NOW
+$59.7M
5
CRM icon
Salesforce
CRM
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 65.36%
2 Technology 6.7%
3 Consumer Discretionary 5.89%
4 Financials 4.13%
5 Consumer Staples 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ERAS icon
26
Erasca
ERAS
$6.65B
$55.6M 1.42%
3,434,967
-11,067,037
-76% -$131M
COF icon
27
Capital One
COF
$128B
$55.2M 1.41%
302,400
+130,430
+76% +$27.3M
ZURA icon
28
Zura Bio
ZURA
$518M
$53.9M 1.38%
9,067,001
+3,500,000
+63% +$21.1M
AMZN icon
29
Amazon
AMZN
$2.66T
$52.9M 1.35%
254,009
-152,137
-37% -$33.5M
AMD icon
30
Advanced Micro Devices
AMD
$808B
$52.3M 1.34%
257,240
-132,336
-34% -$28.3M
FULC icon
31
Fulcrum Therapeutics
FULC
$243M
$50.3M 1.29%
6,561,111
– –
VMC icon
32
Vulcan Materials
VMC
$37.4B
$49.4M 1.26%
+181,594
New +$53.4M
FERG icon
33
Ferguson
FERG
$45B
$49.4M 1.26%
211,900
+52,710
+33% +$12.8M
APO icon
34
Apollo Global Management
APO
$69.5B
$43.2M 1.1%
387,700
-155,190
-29% -$19.2M
MLYS icon
35
Mineralys Therapeutics
MLYS
$2.39B
$41.7M 1.06%
1,538,662
– –
CRNX icon
36
Crinetics Pharmaceuticals
CRNX
$8.88B
$37.9M 0.97%
+1,043,879
New +$46.6M
CTNM
37
Contineum Therapeutics
CTNM
$532M
$37.1M 0.95%
2,841,334
– –
USFD icon
38
US Foods
USFD
$21.4B
$36.5M 0.93%
+395,970
New +$35.1M
PFGC icon
39
Performance Food Group
PFGC
$17.6B
$33.1M 0.85%
+386,885
New +$35.4M
REPL icon
40
Replimune Group
REPL
$859M
$32.3M 0.82%
4,221,836
+4,185,798
+11,615% +$32M
MSOS icon
41
AdvisorShares Pure US Cannabis ETF
MSOS
$905M
$32.1M 0.82%
9,046,200
+376,600
+4% +$1.54M
AURA icon
42
Aura Biosciences
AURA
$723M
$29.3M 0.75%
4,372,884
– –
UNH icon
43
UnitedHealth
UNH
$387B
$27.2M 0.7%
100,630
-10,690
-10% -$3.18M
PROK icon
44
ProKidney
PROK
$332M
$22.1M 0.56%
12,341,266
– –
LTH icon
45
Life Time Group Holdings
LTH
$9.38B
$13.7M 0.35%
+510,349
New +$14.1M
WHWK
46
Whitehawk Therapeutics
WHWK
$192M
$12.8M 0.33%
3,700,000
– –
ABEO icon
47
Abeona Therapeutics
ABEO
$399M
$12M 0.31%
2,676,000
– –
WING icon
48
Wingstop
WING
$3.88B
$9.22M 0.24%
+59,500
New +$14.3M
MOLN
49
Molecular Partners
MOLN
$146M
$8.82M 0.23%
2,221,494
– –
BSX icon
50
Boston Scientific
BSX
$65.4B
$7.78M 0.2%
123,941
-229,620
-65% -$18.4M
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Suvretta Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Suvretta Capital Management held 108 positions worth $3.92B, down 20% from $4.88B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management withdrew a net $852M in Q1 2026, closing 19 positions and reducing 16 holdings. Its most notable exit was Coca-Cola, an estimated $96.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 51% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Suvretta Capital Management opened a new position in Veradermics Inc worth $263M.

  • Suvretta Capital Management's largest Q1 2026 buy was Veradermics Inc: 4,168,970 shares worth $263M.
  • Suvretta Capital Management added most to Capricor Therapeutics in Q1 2026, an estimated $54.2M increase.
  • Suvretta Capital Management's biggest Q1 2026 reduction was Erasca, cutting an estimated $131M.
  • Suvretta Capital Management fully exited Coca-Cola in Q1 2026, selling an estimated $96.7M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.92B portfolio in Q1 2026.
  • Suvretta Capital Management opened 15 new positions and closed 19 in Q1 2026.
  • Suvretta Capital Management's portfolio value fell 20% quarter-over-quarter to $3.92B.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.